Matthew Hewitt

Stock Analyst at Craig-Hallum

(2.48)
# 2,189
Out of 4,789 analysts
2
Total ratings
50%
Success rate
23.17%
Average return

Stocks Rated by Matthew Hewitt

Lifecore Biomedical
Nov 22, 2024
Maintains: Buy
Price Target: $8$10
Current: $7.03
Upside: +42.25%